fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

What is metformin’s secret sauce?

Written by | 7 Jan 2025

Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The “wonder drug” has also been shown to slow cancer growth, improve COVID outcomes… read more.

Metformin and SGLT2 inhibitors show lower dementia and Alzheimer’s risks than other antidiabetic treatments

Written by | 22 Jul 2024

A large retrospective analysis of the cognitive effects of various antidiabetic treatments has disclosed that the risks of dementia and Alzheimer’s disease (AD) were significantly lower in patients… read more.

Promising role of antidiabetic drug in cancer control

Written by | 15 Jun 2024

Flinders University researchers have analysed how an antidiabetic treatment could help control the growth of tumours, potentially paving the way for the design of better cancer treatments. The… read more.

Metformin appears to reduce the risk of blood cancer

Written by | 23 May 2024

Patients who are treated with metformin for type 2 diabetes are less likely to develop a myeloproliferative neoplasm (MPN). Myeloproliferative neoplasms are cancers that occur when the body… read more.

Diabetes drugs appear to lower colorectal cancer risk

Written by | 16 Dec 2023

Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7,… read more.

A common diabetes drug has a surprising side gig: muscle protector

Written by | 31 Jul 2023

You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular… read more.

Metformin lowers risk of long COVID

Written by | 10 Jun 2023

Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on… read more.

Metformin reduces risk of joint replacement in diabetes patients

Written by | 19 Dec 2022

Metformin use appears to lower the risk of total joint replacement in patients with type 2 diabetes. Researchers reported this finding on December 19, 2022 in the CMAJ/Canadian… read more.

Older diabetes treatment appears to have anti-dementia effect

Written by | 22 Oct 2022

Researchers report a link between use of glitazones to treat type 2 diabetes and a 22% reduced risk of dementia. The findings appeared on Oct 11, 2022 in… read more.

Metformin appears to slow cognitive decline in Type 2 Diabetes

Written by | 10 Oct 2020

Article written by Bruce Sylvester Treatment of Type 2 diabetes with metformin appears to inhibit cognitive decline and development of dementia in older patients, researchers reported on Sept…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.